National campaign aims to treat high blood pressure with evidenced-based care.
The risks of poorly controlled high blood pressure have been known for over a century, and effective treatments have been available for more than 50 years. Still, less than half of 67 million American adults with high blood pressure have their condition under control, according to the Centers for Disease Control and Prevention (CDC).
High blood pressure is one of the most significant risk factors for heart disease, stroke and kidney failure and ranks among the leading causes of death. Nearly one in three American adults has high blood pressure, and the costs-including healthcare services, medications and missed days of work-are estimated at $156 billion annually. It is also one of the most common reasons for visiting a physician.
By 2030, an estimated 100 million adults in the United States will have high blood pressure, resulting in staggering increases in healthcare costs and disability as well as lost productivity.
Blood pressure control has been challenging, mainly because it is a silent condition. For this reason, patients might not adhere to recommended medication or lifestyle regimens, physicians might not treat hypertension as an urgent issue, and high blood pressure may not get the public recognition and “call to action” that other diseases receive.
CALL TO ACTION
Our current health system was designed to address acute medical problems, and chronic conditions require team-based, longitudinal care with advanced information technology and patient-centered care at its core.
The American Medical Group Assn. (AMGA) has seized the challenge with a national campaign called Measure Up, Pressure Down. AMGA members are leaders in delivering coordinated, team-based care-resulting in lower costs and better outcomes for patients-so they are uniquely positioned to lead the charge.
The goal of the three-year campaign is to get doctors, nurses and the entire healthcare team working together to achieve control of
the condition by 2016 for 80% of their high blood pressure patient population. So far, over 120 medical groups and health systems
delivering care to more than 40 million patients have already joined Measure Up, Pressure Down.
Groups participating in the campaign are asked to do three things:
Improving high blood pressure will require an expanded effort and increased focus from healthcare systems, clinicians and individuals.
Raising awareness among patients, communities, employers, policymakers and the media will also be necessary.
For this reason, AMGA has teamed up with the U.S. Department of Health and Human Services’ Million Hearts initiative,
Institute for Healthcare Improvement, Association of Black Cardiologists and others.
This national quality initiative has the potential for improving care and empowering patients, saving lives and enhancing the quality of life for people living with high blood pressure and related chronic conditions. MHE
Conversations with Perry and Friends: Saar Mahna, J.D., MBA
July 7th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the "Conversations with Perry and Friends" podcast. In this episode, Cohen speaks with Saar Mahna, J.D., MBA, CEO and founder of Banjo Health, an artificial intelligence company focused on prior authorization.
Listen
Sexual Health and HIV Care Integration Key to Better Care | IAS 2025
July 14th 2025Integrating HIV and sexual health care is essential for improving outcomes, but global stigma, funding cuts—especially the defunding of USAID—and structural barriers like limited access and political resistance continue to hinder progress, experts emphasized at IAS 2025.
Read More
Conversations With Perry and Friends: Paul Fronstin, Ph.D.
May 9th 2025Perry Cohen, Pharm.D., a longtime member of the Managed Healthcare Executive editorial advisory board, is host of the Conversations with Perry and Friends podcast. In this episode, his guest is Paul Fronstin, Ph.D., director of health benefits research at the Employee Benefit Research Institute.
Listen
FDA Expands Kerendia’s Use to Treat Common Form of Heart Failure
July 14th 2025Kerendia was originally approved in July 2021 to reduce cardiovascular and kidney complications in patients with chronic kidney disease (CKD) associated with type 2 diabetes. This new approval extends its use to a broader patient population.
Read More
Black Women Can Successfully Be Started on Long-Acting Apretude for HIV PrEP | IAS 2025
July 14th 2025Increasing the use of Apretude among Black women requires not only expanding awareness of the long-acting PrEP regimen in various clinics but also providing more flexible scheduling and partnering with specialty pharmacies.
Read More